Please check your internet connection and try again.
It appears you are referencing **Claritin (Loratadine)**. Please confirm if this is the correct medication.
# Claritin (Loratadine)
## Overview
Loratadine is a long-acting, non-sedating, peripheral histamine H1-receptor antagonist. It is a second-generation antihistamine with minimal anticholinergic or central nervous system effects.
## Primary Indications
* Allergic rhinitis (seasonal and perennial).
* Chronic idiopathic urticaria.
## Adult Dosing
* **Standard dose:** 10 mg orally once daily.
* **Maximum dose:** 10 mg per 24 hours.
## Pediatric Dosing
* **Children 2 to 5 years (syrup):** 5 mg orally once daily.
* **Children 6 years and older:** 10 mg (tablet or syrup) orally once daily.
## Dose Adjustments
* **Renal Impairment:** Reduce dose to 10 mg every other day for patients with eGFR <30 mL/min/1.73m².
* **Hepatic Impairment:** Reduce dose to 10 mg every other day for patients with severe hepatic impairment.
## Contraindications
* Hypersensitivity to loratadine or any inactive ingredients in the formulation.
## Adverse Effects
* **Common:** Headache, somnolence (rare at recommended doses), fatigue, dry mouth, and pharyngitis.
* **Serious:** Rare reports of hepatotoxicity, anaphylaxis, or seizures (primarily in overdose).
## Key Drug Interactions
* **CYP3A4/2D6 Inhibitors:** Medications such as ketoconazole, erythromycin, or cimetidine may increase plasma concentrations of loratadine; clinical significance is generally low due to the wide therapeutic index.
* **CNS Depressants:** While minimally sedating, monitor for additive effects if combined with alcohol or benzodiazepines.
## Monitoring
* Monitor for symptom relief (rhinitis/urticaria control).
* Assess for excessive sedation or paradoxical stimulation if used in sensitive populations.
## Clinical Pearls
* **Onset:** Effects typically begin within 1–3 hours.
* **Non-sedating:** Unlike first-generation antihistamines (e.g., diphenhydramine), loratadine is preferred for patients requiring daytime alertness.
* **Formulations:** Tablets, rapid-dissolve tablets, and syrup are available.
* **Consistency:** Take consistently to maintain steady-state efficacy for chronic conditions.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice and regional protocols vary. Always verify specific dosing, safety data, and the most current prescribing information via the package insert or professional clinical databases (e.g., Lexicomp, UpToDate) before prescribing or administering medication.
